---
title: "ACE2 Polymorphisms rs2285666 and rs147311723 Linked to Inflammation in COVID‑19 and TB Co‑infection"
id: "medrxiv-21-ace2-polymorphisms-rs2285666-and-rs147311723-are-clinically-relevant-variants"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-21-ace2-polymorphisms-rs2285666-and-rs147311723-are-clinically-relevant-variants"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.11.26362837v1?rss=1"
published_at: "2026-09-13T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# ACE2 Polymorphisms rs2285666 and rs147311723 Linked to Inflammation in COVID‑19 and TB Co‑infection
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-21-ace2-polymorphisms-rs2285666-and-rs147311723-are-clinically-relevant-variants
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.11.26362837v1?rss=1)
- **Published At:** 2026-09-13T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective cross-sectional preprint investigated ACE2 genetic variation and its association with inflammatory and biochemical markers in patients with SARS-CoV-2, Mycobacterium tuberculosis (TB), TB/COVID-19 co-infection, and infection-negative controls in Yaounde, Cameroon. - The study included 120 symptomatic individuals recruited between September 2020 and December 2023 from four hospitals; diagnoses were confirmed by RT‑PCR for SARS‑CoV‑2 and standard microbiological methods for TB. - Serum biochemical markers and cytokines were measured; ACE2 genotypes were determined using **TaqMan** assays targeting multiple single-nucleotide polymorphisms (SNPs) including **rs2285666** and **rs147311723**. - Statistical analysis found a significant association between ACE2 expression and inflammatory/biochemical markers, with particularly strong signals for **rs147311723**. - Several ACE2 variants—**rs6632677**, **rs147311723**, **rs4646140**, **rs2285666**, and **rs4646142**—were significantly associated with increased pro-inflammatory cytokine levels. - Selected biochemical parameters showed suggestive associations with ACE2 variants: creatinine with **rs147311723** (p = 0.0522), AST with **rs2285666** (p = 0.0536), and ALT with **rs4646142** (p = 0.0582), indicating possible renal and hepatic involvement linked to ACE2 genotype. - Principal component analysis identified distinct immunometabolic profiles across patient groups; co-infected individuals exhibited heightened inflammatory and metabolic perturbations relative to other groups. - Authors conclude ACE2 genetic variability appears to modulate inflammatory responses and may contribute to organ-specific dysfunction in COVID‑19 and TB; they emphasize the need for larger, diverse-population studies to validate these associations. - This work is a preprint and has not undergone peer review; data and methods are reported in the manuscript and ethical approval was obtained from the regional ethical committee of research for human health in Yaoundé, Cameroon.
## Clinical Analysis & Structured Key Points
ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. | medRxiv Skip to main content ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. View ORCID Profile Mary Ngongang Kameni , Assam Assam Jean Paul , Eric Berenger Tchoupe , Noubissi Toyim Albert , Ange Maxime Tchoutang , Maloba Franklin , Tsague Voufo Svetlana Carel , Kameni Georgette Njila , View ORCID Profile Fuh Roger Neba , Severin Donald Kamdem , Palmer Masumbe Netongo doi: https://doi.org/10.64898/2026.09.11.26362837 Mary Ngongang Kameni 1 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon, University of Yaounde I Faculty of Sciences: Universite de Yaounde I Faculte des Sciences; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Mary Ngongang Kameni Assam Assam Jean Paul 2 Department of Microbiology, University of Yaounde I, Yaounde, Cameroon; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Eric Berenger Tchoupe 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Noubissi Toyim Albert 2 Department of Microbiology, University of Yaounde I, Yaounde, Cameroon; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ange Maxime Tchoutang 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Maloba Franklin 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Tsague Voufo Svetlana Carel 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Kameni Georgette Njila 4 Department of Microbiology, University of Yaounde I, Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Fuh Roger Neba 5 Catholic University of Central Africa: Universite Catholique de l'Afrique Centrale Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Fuh Roger Neba Severin Donald Kamdem 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Palmer Masumbe Netongo 3 Molecular Diagnostics Research Group, Biotechnology Centre-University of Yaounde I (MDRG-BTC UYI), Yaounde, Cameroon,; Find this author on Google Scholar Find this author on PubMed Search for this author on this site For correspondence: masumben{at}gmail.com Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) enters host cells primarily through the angiotensin-converting enzyme 2 (ACE2) receptor. Genetic variation in the ACE2 gene may influence host inflammatory responses and clinical outcomes during COVID-19. Tuberculosis (TB) on the other hand increases the level of ACE2 expression through interferon stimulation. The objective of this study was to investigate the association between specific single-nucleotide polymorphism (SNP) in the ACE2 gene and their impact on susceptibility to and severity of SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. Methods: This retrospective cross-sectional study included 120 symptomatic individuals recruited between September 2020 and December 2023 from four hospitals in Yaounde, Cameroon. Participants were classified into four groups: COVID-19, TB, TB/COVID-19 co-infection, and infection-negative controls. Diagnoses were confirmed using RT-PCR and standard microbiological methods. Serum biochemical markers and cytokines were quantified, and genotyping of ACE2 polymorphisms was performed using TaqMan assays. Results: Statistical analysis showed a significant association between ACE2 expression and inflammatory or biochemical markers, particularly for rs147311723. Several ACE2 polymorphisms (rs6632677, rs147311723, rs4646140, rs2285666, and rs4646142) were significantly associated with increased pro-inflammatory cytokine levels. Selected biochemical parameters demonstrated suggestive associations with ACE2 variants, including creatinine (rs147311723, p = 0.0522), AST (rs2285666, p = 0.0536), and ALT (rs4646142, p = 0.0582), indicating potential renal and hepatic involvement. Principal component analysis identified distinct immunometabolic profiles across patient groups, with co-infected individuals exhibiting heightened inflammatory and metabolic perturbations. Conclusions: These findings suggest that ACE2 genetic variability is associated with modulation of inflammatory responses and may contribute to organ-specific dysfunction in COVID-19 and TB across different populations. This highlights the potential role of host genetics in shaping disease severity and underscore the need for larger studies to validate these associations in diverse populations. Keywords: ACE2 polymorphisms; COVID-19; tuberculosis; co-infection; cytokines; biomarkers; genetic susceptibility; Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee/IRB of regional ethical committee of research for human health in Yaoundé, Cameroon gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present work are contained in the manuscript Funder Information Declared African coaLition for Epidemic Research, Response and Training (ALERRT) , RIA2016E-1612 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Back to top Previous Next Posted September 13, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. Mary Ngongang Kameni , Assam Assam Jean Paul , Eric Berenger Tchoupe , Noubissi Toyim Albert , Ange Maxime Tchoutang , Maloba Franklin , Tsague Voufo Svetlana Carel , Kameni Georgette Njila , Fuh Roger Neba , Severin Donald Kamdem , Palmer Masumbe Netongo medRxiv 2026.09.11.26362837; doi: https://doi.org/10.64898/2026.09.11.26362837 Share This Article: Copy Citation Tools ACE2 Polymorphisms rs2285666 and rs147311723 Are Clinically Relevant Variants in SARS-CoV-2 and Mycobacterium tuberculosis Co-infection. Mary Ngongang Kameni , Assam Assam Jean Paul , Eric Berenger Tchoupe , Noubissi Toyim Albert , Ange Maxime Tchoutang , Maloba Franklin , Tsague Voufo Svetlana Carel , Kameni Georgette Njila , Fuh Roger Neba , Severin Donald Kamdem , Palmer Masumbe Netongo medRxiv 2026.09.11.26362837; doi: https://doi.org/10.64898/2026.09.11.26362837 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Infectious Diseases (except HIV/AIDS) Subject Areas All Articles Addiction Medicine (617) Allergy and Immunology (900) Anesthesia (330) Cardiovascular Medicine (4805) Dentistry and Oral Medicine (478) Dermatology (414) Emergency Medicine (648) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1625) Epidemiology (15927) Forensic Medicine (32) Gastroenterology (1202) Genetic and Genomic Medicine (7038) Geriatric Medicine (733) Health Economics (1064) Health Informatics (5034) Health Policy (1432) Health Systems and Quality Improvement (1758) Hematology (584) HIV/AIDS (1344) Infectious Diseases (except HIV/AIDS) (16283) Intensive Care and Critical Care Medicine (1170) Medical Education (667) Medical Ethics (153) Nephrology (722) Neurology (7261) Nursing (366) Nutrition (1080) Obstetrics and Gynecology (1240) Occupational and Environmental Health (1004) Oncology (3603) Ophthalmology (1049) Orthopedics (397) Otolaryngology (453) Pain Medicine (470) Palliative Medicine (139) Pathology (706) Pediatrics (1797) Pharmacology and Therapeutics (737) Primary Care Research (765) Psychiatry and Clinical Psychology (5887) Public and Global Health (9744) Radiology and Imaging (2413) Rehabilitation Medicine and Physical Therapy (1448) Respiratory Medicine (1247) Rheumatology (640) Sexual and Reproductive Health (771) Sports Medicine (578) Surgery (775) Toxicology (107) Transplantation (304) Urology (291)
## Related Clinical Research

- [Burden of RSV Hospitalizations in Brazilian Adults Aged ≥60 Years (2013–2024)](https://medichelpline.com/clinical-feed/pubmed-42758792.md) (DOI: 10.1371/journal.pone.0357303)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Kennedy renews attacks on vaccines at Children’s Health Defense conference](https://medichelpline.com/clinical-feed/stat-news-1-kennedy-renews-attacks-on-vaccines-at-children-s-health-defense-conference.md)
- [Study says purer fentanyl won’t by itself explain U.S. overdose death decline](https://medichelpline.com/clinical-feed/stat-news-2-purer-fentanyl-won-t-solve-the-u-s-overdose-death-crisis-study-says.md)
- [Temporal patterns of tuberculosis-associated hyperglycaemia and effects on treatment outcomes in n](https://medichelpline.com/clinical-feed/plos-one-0-temporal-patterns-of-tuberculosis-associated-hyperglycaemia-and-its-effect-on.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.